Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ljiljana Beslac Bumbasirevic"'
Autor:
Darija Kisic-Tepavcevic, Angelina Skodric, Tatjana Pekmezovic, Dejana R. Jovanović, Gorica Maric, Ljiljana Beslac-Bumbasirevic
Publikováno v:
Vojnosanitetski Pregled, Vol 76, Iss 4, Pp 373-378 (2019)
Vojnosanitetski pregled (2019) 76(4):373-378
Vojnosanitetski pregled (2019) 76(4):373-378
Background/Aim. Stroke remains one of the leading causes of death and disability worldwide. The aim of the study was to determine the nursing care-associated predictors of in-hospital mortality in the patients with acute ischemic stroke (AIS) who wer
Autor:
Dragana Lavrnic, Zorica Stevic, Ivana Basta, Vidosava Rakocevic-Stojanovic, Olivera Stojiljkovic, Stojan Peric, Ljiljana Beslac-Bumbasirevic, Bogdan Bjelica, Ivana Berisavac, Ivo Bozovic
Publikováno v:
Journal of the Peripheral Nervous System. 22:127-130
We sought to determine influence of diabetes mellitus on Guillain-Barre syndrome (GBS) course and short-term prognosis. Among the 257 GBS patients included in this retrospective study, diabetes mellitus was present in 17%. The degree of disability at
Autor:
Marko Ercegovac, Predrag Stanarcevic, Maja Stefanovic Budimkic, Tatjana Pekmezovic, Ivana Berisavac, Dejana R. Jovanović, Ljiljana Beslac-Bumbasirevic, Visnja Padjen
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 26:196-203
Background and Purpose It remains unclear if intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator has an impact on the survival and maintenance of a favorable effect on functional recovery over a long follow-up period. The aim
Autor:
Veljko Maksic, Katarina Kacar, Milka Grk, Milica Pešić, Marija Dusanovic Pjevic, Biljana Jekic, Tatjana Damnjanovic, Milan Savic, Ivana Novakovic, Nela Maksimovic, Ljiljana Beslac Bumbasirevic, Dijana Perovic, Ljubica Vojvodic, Jelena Trickovic
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 22, Iss 1 (2019)
Purpose: Treatment of Ischemic stroke (IS) in acute phase is based on the use of thrombolytic rt-PA therapy. We aimed to determine whether different alleles and genotypes of I/D ACE gene and 4G/5G PAI-1 gene polymorphisms may influence outcome of rt-
Autor:
Dragana Lavrnic, Ivana Basta, Milan Cvijanovic, Ljiljana Beslac-Bumbasirevic, Olivera Stojiljkovic Tamas, Aleksandra Dominovic-Kovacevic, Ivana Berisavac, Sonja Rajic, Stojan Peric, Milica Babic
Publikováno v:
Journal of the Peripheral Nervous System. 21:105-110
The aim of the study was to analyze specific features of Guillain-Barre syndrome (GBS) in old people. The study included 403 GBS patients (62% young [ 80 years]). Diagnosis of GBS was made according to the National Institute of Neurological Disorders
Publikováno v:
Medicinski Podmladak, Vol 67, Iss 1, Pp 29-34 (2016)
Atrial fibrillation (AF) is an independent risk factor that increases the risk of acute ischemic stroke by five-fold. In addition, it is also a significant predictor of stroke's poor outcome. The aim of this article was to provide an overview on curr
Autor:
Maja S Budimkić-Stefanović, Ljiljana Beslac-Bumbasirevic, Milan Radovic, Visnja Padjen, Marko Ercegovac, Predrag Stanarcevic, Dejana R. Jovanović, Ivana Berisavac
Publikováno v:
Neurology India. 65(1)
Metabolic encephalopathy (ME) represents a syndrome of temporary or permanent disturbance of brain functions that occurs in different diseases and varies in clinical presentation. It can be manifested in a range from very mild mental disorders to dee
Autor:
Dragana Lavrnic, Vuk Milosevic, Milica Babic, Ivana Berisavac, Vanja Djuric, Milutin Petrovic, Olivera Stojiljkovic, Aleksandra Dominovic, Milan Cvijanovic, Sonja Rajic, Gordana Toncev, Balsa Vujovic, Mirjana Cukic, Ljiljana Beslac-Bumbasirevic, Vesna Martic, Stojan Peric, Ivan Marjanovic, Gordana Djordjevic, Nenad Komatina
Publikováno v:
Journal of the Peripheral Nervous System. 19:317-321
The aim of this study was to define features of Guillain-Barre syndrome in a large cohort of patients from three Western Balkans countries. Data from adult Guillain-Barre syndrome (GBS) cases from 2009 to 2013 were retrospectively obtained from all t
Autor:
Maja Stefanovic Budimkic, Ivana Berisavac, Marko Ercegovac, Ljiljana Beslac Bumbasirevic, Predrag Stanarcevic, Visnja Padjen, Dejana R. Jovanović
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 23:2199-2205
Background Data based on randomized clinical trials regarding the efficacy and safety of intravenous thrombolysis (IVT) versus placebo or any other antithrombotic agent in the treatment of stroke associated with atrial fibrillation (AF) are unavailab
Autor:
Jörg Berrouschot, Yaohua Chen, Elena Haapaniemi, Didier Leys, Paul J. Nederkoorn, Henrik Gensicke, Mirjam Rachel Heldner, Andrea Zini, Ljiljana Beslac-Bumbasirevic, Patrik Michel, Ville Artto, Sanne M. Zinkstok, Céline Odier, Jukka Putaala, Marcel Arnold, Peter A. Ringleb, Yvo B.W.E.M. Roos, Alessandro Pezzini, Philippe Lyrer, Turgut Tatlisumak, Visnja Padjen, Hakan Sarikaya, Valentina Fioravanti, Stefan T. Engelter
Publikováno v:
Stroke; a journal of cerebral circulation, 44(4), 1080-U234. Lippincott Williams and Wilkins
Background and Purpose— Intravenous thrombolysis for acute ischemic stroke is beneficial within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating quick diagnostic in-hospital work-up. Initial time strain occasion